The Global Carrier Screening Market will be worth USD 6.13 billion by 2027, according to a current analysis by Emergen Research.
The Global Carrier Screening Market will be worth USD 6.13 billion by 2027, according to a current analysis by Emergen Research. The growth of this market can be attributed to the number of initiatives undertaken by key players and various governments across the globe to raise awareness about carrier screening among individuals, the rising number of deaths due to genetic disorders, and the increasing popularity of non-invasive prenatal tests (NIPT). The high cost of carrier screening tests is a major factor restraining market growth. In addition, a lack of awareness about carrier screening among individuals in low- and middle-income countries is expected to challenge market growth over the forecast period.
Key players in the carrier screening market include Natera, Inc., Myriad Genetics, Inc., Counsyl, Inc., Sequenom, Inc., and Ariosa Diagnostics, Inc. These players are focusing on various strategies such as product launches, partnerships, collaborations, and mergers and acquisitions to stay competitive in the market. For instance, in October 2019, Natera, Inc. launched Panorama Non-Invasive Prenatal Test for universal carrier screening in the U.S. This test can be used for any individual of reproductive age and detects more than 100 conditions, including 22, X and XY aneuploidies. It is the only test that can be used for carrier screening for Lynch syndrome and familial dysautonomia.
Carrier Screening is a method used to identify individuals who are carriers of genetic conditions. Carrier screening can be used to detect genetic conditions that are passed down from parents to children. Carrier screening can also be used to detect genetic conditions that may not be detectable until later in life. Carrier screening is an important tool for couples who are planning on having children. Carrier screening can help couples identify genetic conditions that they may be at risk for passing on to their children. Carrier screening can also help couples make informed decisions about their reproductive options.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/235
Moreover, as a result of the testing kits becoming increasingly portable and user friendly, the number of genetic tests being performed in remote & rural areas is also on the rise. This is likely to create significant opportunities for the growth of the carrier screening market in the near future.
Key Highlights From The Report
- On the basis of technology, the market has been divided into sequencing-based tests, microarray-based tests, and targeted panel tests. The sequencing-based tests segment held the largest share of the market in 2019 and is expected to grow at the fastest CAGR during the forecast period. This growth can be attributed to the rising popularity of next-generation sequencing (NGS) technology.
- On the basis of disease type, the carrier screening market has been bifurcated into cystic fibrosis, spinal muscular atrophy, fragile X syndrome, sickle cell anemia, and thalassemia. The fragile X syndrome segment held the largest share of the market in 2019 due to the high prevalence of this disease and the development of new treatment options.
- On the basis of end user, the carrier screening market has been classified into hospitals, diagnostic centers, and others. The hospitals segment held the largest share of the market in 2019 due to the increasing number of newborns with genetic disorders and the availability of sophisticated facilities for diagnosis and treatment.
- On the basis of region, the carrier screening market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the largest share of the market in 2019 due to the availability of advanced healthcare infrastructure and the presence of key players in this region.
- The Asia Pacific is expected to grow at the fastest CAGR during the forecast period due to the rising number of births, the growing awareness about genetic disorders, and the increasing availability of carrier screening tests.
- Key participants MedGenome Inc., Luminex Corporation, Illumina Inc., Otogenetics Corporation, Myriad Genetics Inc., Thermo Fisher Scientific Inc., Natera Inc., Gene By Gene Ltd., Corporation of America Holdings, and Mount Sinai Genomics Inc., among others.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/carrier-screening-market
For the purpose of this report, Emergen Research has segmented the Global Carrier Screening Market on the technology, end-user, medical condition, and region:
Technology Outlook (Revenue, USD Billion; 2017-2027)
- DNA Sequencing
- Polymerase Chain Reaction
- Microarrays
- Others
End-User Outlook (Revenue, USD Billion; 2017-2027)
- Hospitals
- Reference Laboratories
- Physician Offices and Clinics
- Others
Medical Condition Outlook (Revenue, USD Billion; 2017-2027)
- Pulmonary Conditions
- Hematological Conditions
- Neurological Conditions
- Others
Regional Outlook (Revenue: USD Billion; 2017-2027)
- North America
- U.S.
- Canada
- Mexico
- Europe
- U.K.
- Germany
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- Rest of MEA
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/235
Explore More Reports Emergen Research:
electric vehicle charging station market
electric vehicle charging infrastructure market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Press Release Available @ https://www.emergenresearch.com/press-release/global-carrier-screening-market
Read Blog Article@ https://www.emergenresearch.com/blog/top-8-leading-companies-in-the-carrier-screening-market